Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.

BACKGROUND Osteoporosis diminishes the quality of life in adults with cystic fibrosis (CF). Vitamin D deficiency resulting from malabsorption may be a factor in the etiology of low bone mineral density (BMD) in patients with CF. OBJECTIVE Absorption of oral ergocalciferol (vitamin D2) and the consequent response of 25-hydroxyvitamin D in 10 adults with CF and exocrine pancreatic insufficiency was compared with that of 10 healthy control subjects. DESIGN In this pharmacokinetic study, CF patients and control subjects were pair-matched on age, sex, and race. Each subject consumed 2500 microg oral vitamin D2 with a meal. The CF group also took pancreatic enzymes that provided > or = 80000 U lipase. Blood samples were obtained at baseline and at 5, 10, 24, 30, and 36 h after vitamin D2 consumption to measure serum vitamin D2 and 25-hydroxyvitamin D concentrations. RESULTS Vitamin D2 concentrations in all subjects were near zero at baseline. CF patients absorbed less than one-half the amount of oral vitamin D2 that was absorbed by control subjects (P < 0.001). Absorption by the CF patients varied greatly; 2 patients absorbed virtually no vitamin D2. The rise in 25-hydroxyvitamin D in response to vitamin D2 absorption was significantly lower over time in the CF group than in the control group (P = 0.0012). CONCLUSIONS Vitamin D2 absorption was significantly lower in CF patients than in control subjects. These results may help explain the etiology of vitamin D deficiency in CF patients, which may contribute to their low BMD.

[1]  C. Weaver.  Calcium requirements of physically active people. , 2000, The American journal of clinical nutrition.

[2]  J. Stakkestad,et al.  The Sp1 binding site polymorphism in the collagen type I alpha 1 (COLIA1) gene is not associated with bone mineral density in healthy children, adolescents, and young adults. , 2000, European journal of endocrinology.

[3]  L. Kuller,et al.  Factors associated with calcium absorption efficiency in pre- and perimenopausal women. , 2000, The American journal of clinical nutrition.

[4]  T. Binkley,et al.  High Bone Mass in a Female Hutterite Population , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  E. Molaison.  Estrogen replacement therapy: a possible mode of combating the effects of renal osteodystrophy? , 2000, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[6]  I. Lambrinoudaki,et al.  Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study. , 2000, The Journal of rheumatology.

[7]  B. Dawson-Hughes,et al.  Plasma 25-hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. , 1999, Journal of the American College of Nutrition.

[8]  R. Vieth,et al.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.

[9]  R. Aris,et al.  Altered Calcium Homeostasis in Adults with Cystic Fibrosis , 1999, Osteoporosis International.

[10]  J. Adams,et al.  Osteoporosis in adults with cystic fibrosis , 1998, Journal of the Royal Society of Medicine.

[11]  C. Haworth,et al.  Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis , 1998, The Lancet.

[12]  R. Vieth,et al.  Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. , 1998, The American journal of clinical nutrition.

[13]  J. Treluyer,et al.  Drug Disposition in Cystic Fibrosis , 1998, Clinical pharmacokinetics.

[14]  S. Ott,et al.  Osteoporosis in patients with cystic fibrosis. , 1998, Clinics in chest medicine.

[15]  R. Lindsay,et al.  Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. , 1998, American journal of respiratory and critical care medicine.

[16]  J. Renner,et al.  Increased Rate of Fractures and Severe Kyphosis: Sequelae of Living into Adulthood with Cystic Fibrosis , 1998, Annals of Internal Medicine.

[17]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[18]  L. Molinari,et al.  Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals. , 1996, The American journal of clinical nutrition.

[19]  T. Egan,et al.  Severe osteoporosis before and after lung transplantation. , 1996, Chest.

[20]  F. Muskiet,et al.  Changes in vitamin-D metabolites and parathyroid hormone in plasma following cholecalciferol administration to pre- and postmenopausal women in the Netherlands in early spring and to postmenopausal women in Curaçao , 1996, British Journal of Nutrition.

[21]  R. Marcus,et al.  Correlates of osteopenia in patients with cystic fibrosis. , 1996, Pediatrics.

[22]  C. Madsen,et al.  Bone density in children and adolescents with cystic fibrosis. , 1996, The Journal of pediatrics.

[23]  M. Konstan,et al.  Inflammatory cytokines in cystic fibrosis lungs. , 1995, American journal of respiratory and critical care medicine.

[24]  R. Marcus,et al.  Osteopenia in adults with cystic fibrosis , 1994 .

[25]  S. Fitzsimmons,et al.  The changing epidemiology of cystic fibrosis. , 1993, The Journal of pediatrics.

[26]  M. McKenna,et al.  Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. , 1985, The Quarterly journal of medicine.